Physician profile
Deepak Kumar
NPI 1063679520
$1,740.33
in general payments reported to CMS, 2019-2025
17 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $531 · 2020: $86.23 · 2021: $241 · 2022: $294 · 2023: $279 · 2024: $203 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $821.74 | 2019-2025 | |
| Pfizer INC. | $314.71 | 2019-2023 | |
| Ucb, INC. | $98.58 | 2024-2025 | Cimzia, Bimzelx |
| Amgen INC. | $76.64 | 2019-2024 | Enbrel, Tavneos |
| E.R. Squibb & Sons, L.L.C. | $73.46 | 2023-2024 | Orencia |
| Glaxosmithkline, LLC. | $71.93 | 2022-2023 | Benlysta |
| Aurinia Pharma U.S., INC. | $68.81 | 2021-2024 | Lupkynis |
| Astrazeneca Pharmaceuticals Lp | $31.77 | 2022-2023 | Saphnelo |
| Genzyme Corporation | $29.68 | 2023 | |
| Abbott Laboratories | $25.92 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Actelion Pharmaceuticals US, INC. | $25.59 | 2022 | |
| Nevro Corp. | $24.11 | 2023 | Senza |
| Organon LLC | $20.36 | 2025 | Hadlima |
| Novartis Pharmaceuticals Corporation | $17.49 | 2019 | |
| Hikma Pharmaceuticals USA | $14.25 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $14.18 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.